CLR Berlin to launch C. acnes inhibiting active ingredient

27-Feb-2020

CLR Berlin to launch C. acnes inhibiting active ingredient

CLR Berlin is introducing a new active ingredient to coincide with the in-cosmetics Global ingredients trade show at the end of March.

CutiBiome CLR has been developed to reduce the negative results of an imbalance in the skin microbiota.

CutiBiome CLR (INCI: Octyldodecanol, Leptospermum scoparium branch/leaf oil, Piper nigrum fruit extract, Magnolia officinalis bark extract) abolishes the film-forming activity and significantly inhibits the growth of Cutibacterium acnes phylotype I-A1, thereby dramatically reducing sebum, comedones, pustules and pimples.

Sign up for your free email newsletter

It has also been proved in vivo to reduce dandruff, as well as scalp oiliness, sensitivity and itching.

Companies